key: cord-0756989-rl19acpv
authors: Aziz, Muhammad; Fatima, Rawish; Lee-Smith, Wade; Assaly, Ragheb
title: The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis
date: 2020-05-26
journal: Crit Care
DOI: 10.1186/s13054-020-02995-3
sha: 0f64dc1ba5c6b12880ddfc628c972a3e105bd70e
doc_id: 756989
cord_uid: rl19acpv

nan

A total of 11 studies (with 910 patients, mean age 47.6 ± 8.2 years and 47.0% females) were included ( Table 1 ). The weighted mean serum albumin on admission was 3.50 g/dL (CI 3.26-3.74 g/dL) and 4.05 g/dL (CI 3.82-4.27 g/dL) in severe and non-severe COVID-19 group, respectively. This was statistically significant (MD:− 0.56 g/dL, CI -0.69 to -0.42 g/dL, p < 0.001, I 2 = 91.2%) (Fig. 1a) . Leave-one-out meta-analysis was consistent with point estimate (MD) ranging from -0.61 to -0.51 g/dL (Fig. 1b) . The results were consistent on subgroup analysis of 8 studies that defined severe COVID-19 based on respiratory distress definition (MD -0.58 g/ dL, 95% CI -0.78 to -0.37 g/dL, p < 0.001, I 2 = 87.9%). Four studies assessed the hypoalbuminemia status and severe COVID-19 and increased risk was demonstrated (OR 12.6, 95% CI 7.5-21.1, p < 0.001, I 2 = 0%) (Fig. 1c) .

Hypoalbuminemia status has been associated with critically ill patients and mortality across numerous clinical settings [13] . The pathophysiology behind hypoalbuminemia in disease state (such as pancreatitis, infection, trauma, burn, and organ dysfunction) is thought to be secondary to increased capillary permeability, decreased protein synthesis, decreased half-life of serum albumin, decreased serum albumin total mass, increased volume of distribution, and increase expression of vascular endothelial growth factor [14] . The hallmark of severe COVID-19 includes the cytokine storm and an interplay of some of the aforementioned mechanisms [1] .

Our study had some limitations. There was lack of reporting on temporal association of hypoalbuminemia and severe COVID-19. The serum albumin level was noted on admission; however, it is difficult to make conclusive evidence whether severe COVID-19 caused hypoalbuminemia or vice versa. We were also not able to address if hypoalbuminemia should be corrected or not in the current study and needs further evaluation in future studies. The strength of our study is the reporting of large cohort of patients with consistent results across subgroup and sensitivity analysis. We demonstrate the association of hypoalbuminemia and severe COVID-19. A low albumin level can potentially lead to early recognition of severe disease and assist clinicians in making informed decision for their patients. 

Elevated interleukin-6 and severe COVID-19: a meta-analysis

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury

Clinical and immunological features of severe and moderate coronavirus disease 2019

Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China

Clinical features and treatment of COVID-19 patients in northeast Chongqing

Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease

Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city

Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus

Low Albumin Levels Are Associated with Mortality Risk in Hospitalized Patients

Pathogenesis and Clinical Significance

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

None

Authors' contributions Muhammad Aziz: planning and conducting the study, collecting, interpreting data, statistical analysis, drafting the manuscript. Rawish Fatima: collecting data, drafting the manuscript. Wade lee-smith: created the search strategy and critical revision of manuscript. Ragheb Assaly: study design and conception, critical revision of the manuscript. The authors read and approved the final manuscript

No funding received for preparing this manuscript. Fig. 1 Forest plot demonstrating a meta-analysis comparing mean serum albumin, b leave-one-out meta-analysis comparing mean serum albumin, and c meta-analysis comparing hypoalbuminemia status for patients in severe vs non-severe group (C.I. confidence interval)

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Not obtained as this is a systematic review and meta-analysis of published studies.

Consent from patients not obtained due to reason above. All authors approved for the submission of the manuscript.

The authors declare no competing/conflict of interest.